Update 1991 pp 549-558 | Cite as

Sedation in Intensive Care

  • M. McD Fisher
  • R. F. Raper
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 14)


The term “sedation” as used by intensivists carries a number of meanings. While traditionally sedation is defined as use of hypnotic-sedative drugs to produce drowsiness, this term is misleading and dates from the days in which barbiturates were the only such drugs available [1]. With the development of “tranquilizers”, the traditional sedative-hypnotic drugs have come to play a lesser role in daytime sedation, although the drugs traditionally classified as tranquilizers are more commonly used in psychiatric disorders than in the intensive care unit (ICU). Indeed, in the ICU the demand for and indication for sedation cover a wide spectrum, and the majority of drugs used have general depressant properties.


Intensive Care Unit Sedative Drug Status Asthmaticus Refractory Status Epilepticus Barbiturate Coma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harvey SC (1975) Hypnotics and sedatives. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. MacMillan, New York, pp 102–123Google Scholar
  2. 2.
    Turner JS, Briggs SJ, Springhorn HE, Potgieter PD (1990) Patients recollection of intensive care experience. Crit Care Med 18:966–968PubMedCrossRefGoogle Scholar
  3. 3.
    Donegan JH, Traystman RJ, Koehler RC, Jones MD, Rogers MC (1985) Cerebrovascular hypoxic and autoregulatory response during reduced brain metabolism in man. Am J Physiol 249:421–429Google Scholar
  4. 4.
    Borel C, Hanley D, Diringer MN, Rogers MC (1990) Intensive care management of severe head injury. Chest 98:180–189PubMedCrossRefGoogle Scholar
  5. 5.
    Cousins MJ, Phillips GD (1981) Pain, anxiety, sleep in critical care: State of the art, vol 2. In: Shoemaker WC, Thompson WL (eds) Society of Critical Care Medicine, Los Angeles, pp 1–42Google Scholar
  6. 6.
    Wallace PAM, Bion JF, Ledingham IMcA (1988) The changing face of sedative practice in intensive care. In: Ledingham I McA (ed) Recent advances in Critical Care Medicine 3:69–94Google Scholar
  7. 7.
    Kiely WF (1974) Psychiatric aspects of intensive care. Crit Care Med 2:139–142PubMedCrossRefGoogle Scholar
  8. 8.
    Dasla JF, Hale KN, Stauffer GL, Tschampel MM (1988) Comparison of visual and turbidimetric methods for determining short term compatibility of intravenous critical care drugs. Am J Hosp Pharm 45:28:2361–2366Google Scholar
  9. 9.
    Runciman WB, Myburgh JA, Upton RN (1990) Pharmacokinetics and pharmacodynamics in the critically ill. In: Dobb GJ (ed) Intensive care: developments and controversies. Ballières Clinical Anesthesiology 4:271–305CrossRefGoogle Scholar
  10. 10.
    Mather LE, Selby DG, Runciman WB (1990) Effects of propofol and thiopentone anaesthesia on the regional kinetics of pethidine in the sleep. Br J Anaesth 65:365–372PubMedCrossRefGoogle Scholar
  11. 11.
    Selby DG, Mather LE, Runciman WB (1990) Effects of propofol and of thiopentone anaesthesia on the renal clearance of cefoxitan in the sleep. Br J Anaesth 65:360–364PubMedCrossRefGoogle Scholar
  12. 12.
    McKeag A (1991) A review of sedation practiced in intensive … (in press)Google Scholar
  13. 13.
    Lamber FA, Mitchell R, Frost J, Ratcliffe JG, Robertson WR (1983) Direct in vitro inhibitions of adrenal steiodogenesis by etomidate. Lancet 2:1270Google Scholar
  14. 14.
    Ward JD, Becker DP, Miller JD, Newton P (1985) Failure of prophylactics barbiturate coma in the treatment of severe head injury. J Neurosurg 62:383–388PubMedCrossRefGoogle Scholar
  15. 15.
    Holaday JW, Bryant HU, Kenner JR, Bernton EW (1989) Brain endocrine and immune interactions: implications in intensive care. In: Bihari D, Holaday JW (eds) Brain failure. (Update in intensive care and emergency medicine, vol 9) Springer, Berlin Heidelberg New York Tokyo, pp 1–14Google Scholar
  16. 16.
    Aitkenhead AA, Willatts SM, Park GK, et al. (1989) Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 2:704–709PubMedCrossRefGoogle Scholar
  17. 17.
    Bion JF, Ledingham I McA (1987) Sedation in intensive care — a postal survey. Intensive Care Med 13:215–216PubMedGoogle Scholar
  18. 18.
    Shelley MP, Mendel L, Park GP (1987) Failure of critically ill patients to metabolise medazolam. Anaesthesia 42:619–626CrossRefGoogle Scholar
  19. 19.
    Dirkson MSC, Vree TB, Driessen JJ (1987) Clinical pharmacokinetics of long term infusion of midazolam in critically ill patients. Anaesth Intens Care 15:440–444Google Scholar
  20. 20.
    Lazarus HR, Hagen SJH (1968) Prevention of psychosis following open heart surgery. Am J Psychiatry 124:1190–1195PubMedGoogle Scholar
  21. 21.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1986) An evaluation of outcome from intensive care in major medical centres. Ann Intern Med 104:410–418PubMedGoogle Scholar
  22. 22.
    Merriman HM (1981) The techniques used to sedate ventilated patients. Intensive Care Med 7:217–218PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1991

Authors and Affiliations

  • M. McD Fisher
  • R. F. Raper

There are no affiliations available

Personalised recommendations